Recent Company News

• 09:17 AM ET Oct 20, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:24 AM ET Oct 20, 2025
  

  StreetAccount Summary - US Pre-market trading

• 07:44 AM ET Oct 20, 2025
  

  Adaptimmune announces delisting of ADSs from Nasdaq ($0.20, 0.00)

• 07:41 AM ET Oct 20, 2025
  

  Adaptimmune Announces Delisting from Nasdaq

• 04:59 PM ET Oct 09, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:47 AM ET Oct 09, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 11:32 AM ET Aug 22, 2025
  

  StreetAccount Activist Summary: Week of 18-Aug

• 07:22 PM ET Aug 19, 2025
  

  Adaptimmune Therapeutics holder New Enterprise Associates discloses sale of 17.1M-ADS (102.5M-share) holding - 13D/A ($0.06, 0.00)

• 07:34 AM ET Aug 13, 2025
  

  Adaptimmune Therapeutics reports Q2 EPS ($0.02) vs FactSet ($0.04) [5 est, ($0.13)-0.00] ($0.08, 0.00)

• 09:53 PM ET Jul 29, 2025
  

  Adaptimmune Therapeutics downgraded to neutral from buy at Guggenheim Securities ($0.10, 0.00)